Aflac Raises Its Dividend 4.9% to 64 Cents for a 44th Straight Year After Third-Quarter Net Earnings Fell to $303 Million
Carl Edwards' No. 99 Ford, sponsored by the Aflac Cancer Center, in the garage at Atlanta Motor Speedway in September 2009. Photo: Hans J E / Wikimedia Commons (CC BY-SA 2.0)
COLUMBUS, Ga. - Aflac Inc. will raise its quarterly dividend 4.9% to 64 cents a share in the first quarter of 2027, keeping alive a streak the Columbus company has guarded for 44 consecutive years. The board's decision, announced Nov. 12, came eight days after Aflac reported that third-quarter net earnings fell to $303 million from $1.6 billion a year earlier, mostly because of losses from reshuffling its investment portfolio. The new dividend is payable March 1 to shareholders of record at the close of business Feb. 17, according to the company.
The increase is measured against the 61 cents a share Aflac declared for the fourth quarter of 2026. That math checks out: 3 cents on a 61-cent base is a 4.9% raise. On an annual basis, four payments of 64 cents add up to $2.56 a share, compared with $2.44 at the current rate.
A smaller raise, but still a raise
The size of the yearly increase has come down from its recent peak. Aflac raised its first-quarter 2025 dividend 16% to 58 cents from 50 cents, according to the company's announcement of that increase. A year ago, on Nov. 11, 2025, it raised the first-quarter 2026 dividend 5.2% to 61 cents, the company said at the time.
| Dividend year | Quarterly rate | Increase |
|---|---|---|
| 2025 | 58 cents | 16.0% |
| 2026 | 61 cents | 5.2% |
| 2027 | 64 cents | 4.9% |
Chairman and CEO Daniel P. Amos framed the move as part of a balance. "We treasure our record of 44 consecutive years of dividend increases," Amos said in the Nov. 12 release, adding that the company's primary responsibility is to meet its promises to policyholders. He said Aflac remains committed to strong capital ratios while balancing that financial strength with "tactical capital deployment."
Why the earnings drop and the dividend can both be true
The headline earnings number and the company's preferred measure tell different stories. Aflac's third-quarter net earnings were $303 million, or 61 cents a diluted share, down from $1.6 billion, or $3.08 a share, according to its Nov. 4 results release. The quarter included $1.1 billion in net investment losses, or $2.15 a share, which the company said came mainly from repositioning its portfolio, including $842 million in losses on sales and redemptions.
Adjusted earnings, which leave out those investment swings, held up far better. Adjusted earnings per diluted share were $2.43, down 2.4% from $2.49, and total adjusted earnings fell 8.5% to $1.214 billion, the release said. The new 64-cent quarterly dividend equals about 26% of that $2.43 adjusted figure, a Columbus Times calculation.
Revenue told a sharper story. Total revenues fell 31% to $3.271 billion from $4.740 billion, the release said, in the same quarter the $1.1 billion in investment losses was recorded. The weaker yen also cut 3 cents from adjusted earnings per share in the quarter, with the average rate at 158.49 yen to the dollar, 6.8% weaker than a year earlier.
Japan slips, the U.S. grows
Aflac operates in two markets, the United States and Japan, and they moved in opposite directions. Aflac Japan's new annualized premium sales fell 4% to 18.8 billion yen, or $118 million, which the company tied to strong year-earlier sales of its Miraito cancer product. Aflac U.S. sales rose 3.5% to $403 million, led by network dental and group life and disability products, the release said.
Buybacks shrink the share count
The dividend is only part of what Aflac sends back to shareholders. The company bought back $804 million of its own stock in the third quarter and paid $305 million in dividends, according to the release. Shares outstanding fell to 495.7 million at Sept. 30 from 525.7 million a year earlier, so each quarterly dividend is paid on fewer shares.
Book value moved in both directions. Shareholders' equity was $29.3 billion, or $59.08 a share, at the end of September, up from $54.57 a share a year earlier, the release said. Adjusted book value excluding foreign currency remeasurement fell to $40.73 a share from $43.52, a reminder that the yen still weighs on the numbers.
What it means at home
Aflac is headquartered in Columbus and describes itself as a Fortune 500 company with operations in the United States and Japan. The company says it ranks first among U.S. supplemental health insurance providers, citing a 2025 LIMRA report. Its ties to the city go beyond the headquarters, too: Aflac and Columbus State University put 20 sophomores in a paid three-year claims co-op, the Columbus Times reported Nov. 12.
For shareholders, the current 61-cent dividend is still on the calendar first. It is payable Dec. 1 to holders of record Nov. 18, according to the third-quarter release. This story reports company filings and is not investment advice.
What to watch next
Aflac's Financial Analysts Briefing is set for Dec. 3, according to the results release, and it is the company's next big chance to explain its plans for capital and investments. The 64-cent payment follows on March 1. Fourth-quarter results will show whether the portfolio repositioning that dented third-quarter net earnings is finished or still under way.
Source: Aflac via PR Newswire (Nov. 12, 2026); Aflac Q3 2026 results (Nov. 4, 2026); Aflac dividend releases (Nov. 11, 2025; Dec. 2024)
News organizations may republish this story with credit. See our guidelines.
Know someone who'd want to read this? Email it to a friend.
Plan your weekend with Columbus Times
Get This Weekend in Columbus every Thursday: the best local events, free things to do and family fun, plus each evening's local news. Free, and you can unsubscribe anytime.
By signing up you agree to get the Columbus Times email newsletter. Unsubscribe anytime with one click.
Comments
Be respectful. No personal attacks, hate speech, spam or anyone's private information. Every comment is reviewed before it appears. Comment rules
No comments yet. Be the first to share your thoughts.